首页> 外文期刊>Asia Medical Devices Report >Switzerland's Medical Device Export Recovery Facing Threat From EU's Medical Device Regulation Implementation
【24h】

Switzerland's Medical Device Export Recovery Facing Threat From EU's Medical Device Regulation Implementation

机译:瑞士的医疗设备出口恢复面临欧盟医疗设备法规实施的威胁

获取原文
获取原文并翻译 | 示例
           

摘要

Switzerland's medical device manufacturers and distributors face short-term risks associated with the implementation of EU Medical Device Regulation (MDR) in May 2021. The EU has still not provided a Mutual Recognition Agreement for Switzerland's new Medical Devices Ordinances. Switzerland is a net exporter of medical devices and will face hurdles if the country is to become a 'third country'to the EU. This would require swiss companies to appoint an importer and an authorised representative in a member state to continue to supply medical devices to the EU. Following the Covid-19 pandemic, the recovery of Swiss medical device exports, and particularly its orthopaedics market, faces a number of risks. In addition to regulatory issues with the EU MDR, a number of key export markets are experiencing a third wave of Covid-19. Further lockdowns across mainland Europe represent a downside risk to our forecast of resurgent demand in 2021.
机译:瑞士的医疗设备制造商和分销商在2021年5月面临与实施欧盟医疗设备法规(MDR)有关的短期风险。欧盟仍未为瑞士的新医疗设备法令提供相互认可协议。 瑞士是医疗设备的净出口国,如果该国成为欧盟第三国,将面临障碍。 这将要求瑞士公司任命成员国的进口商和授权代表继续向欧盟提供医疗设备。 在COVID-19大流行之后,瑞士医疗设备出口,尤其是其骨科市场的恢复面临许多风险。 除了欧盟MDR的监管问题外,许多关键出口市场还经历了第三波Covid-19。 整个欧洲大陆的进一步锁定代表了我们2021年复兴需求预测的下行风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号